Facebook Twitter LinkedIn Google Plus RSS

Antares Pharma enters marketing agreement worth up to $20M for psoriasis treatment

By ,

Ewing-based Antares Pharma Inc. announced today its exclusive promotion and marketing agreement with Denmark-based LEO Pharma regarding the latter company's Otrexup psoriasis treatment.

According to the announcement, Antares will receive a $5 million initial payment and up to $15 million in additional milestone payments. Antares Pharma will record all product revenue associated with future dermatology prescriptions and pay LEO Pharma a percentage of Otrexup net sales generated in dermatology. LEO Pharma will be responsible for promotion and marketing activities in dermatology.

Antares appointed a new senior vice president for medical earlier this month.

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy